227 related articles for article (PubMed ID: 6144791)
1. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
Grega GJ; Barrett RJ; Adamski SW; Lokhandwala MF
J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
[TBL] [Abstract][Full Text] [Related]
3. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
Sabouni MH; Alkadhi KA; Lokhandwala MF
J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
[TBL] [Abstract][Full Text] [Related]
5. Evidence that serotonin receptors mediate the cutaneous vasoconstriction produced by 5-hydroxytryptamine in canine forelimbs.
Dobbins DE; Adamski SW; Lokhandwala MF; Grega GJ
Circ Res; 1983 Oct; 53(4):473-81. PubMed ID: 6627607
[TBL] [Abstract][Full Text] [Related]
6. Effect of dopamine receptor activation on ganglionic transmission and cyclic AMP levels in the stellate ganglia and renal arteries of the dog.
Sabouni MH; Alkadhi KA; Lokhandwala MF
J Pharmacol Exp Ther; 1987 Jan; 240(1):93-8. PubMed ID: 2879905
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
[TBL] [Abstract][Full Text] [Related]
9. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP
J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
[TBL] [Abstract][Full Text] [Related]
10. The role of dopamine receptors in the treatment of congestive heart failure.
Goldberg LI
J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S19-27. PubMed ID: 2478806
[TBL] [Abstract][Full Text] [Related]
11. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Ensinger H; Majewski H; Hedler L; Starke K
J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
[TBL] [Abstract][Full Text] [Related]
12. Dopamine1 receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits.
Szabo B; Hedler L; Starke K
J Pharmacol Exp Ther; 1986 Dec; 239(3):881-6. PubMed ID: 2879034
[TBL] [Abstract][Full Text] [Related]
13. Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney.
Bass AS; Robie NW
J Pharmacol Exp Ther; 1984 Apr; 229(1):67-71. PubMed ID: 6707948
[TBL] [Abstract][Full Text] [Related]
14. Patterns of constriction produced by vasoactive agents.
Grega GJ; Adamski SW
Fed Proc; 1987 Feb; 46(2):270-5. PubMed ID: 3803618
[TBL] [Abstract][Full Text] [Related]
15. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Clark KL; Hilditch A; Robertson MJ; Drew GM
J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
[TBL] [Abstract][Full Text] [Related]
16. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
Satoh Y; Kohli JD; Goldberg LI
J Pharmacol Exp Ther; 1989 Oct; 251(1):253-7. PubMed ID: 2571718
[TBL] [Abstract][Full Text] [Related]
17. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.
Kerns WD; Arena E; Morgan DG
Am J Pathol; 1989 Aug; 135(2):339-49. PubMed ID: 2571297
[TBL] [Abstract][Full Text] [Related]
18. Dissimilarities between droperidol and phentolamine on vascular tone and dopamine and norepinephrine vasoconstriction.
Koehntop DE; Liao JC; Buckley JJ
Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):179-91. PubMed ID: 7163626
[TBL] [Abstract][Full Text] [Related]
19. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
Lokhandwala MF; Sabouni MH
J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor blockade does not affect the natriuresis accompanying sodium chloride infusion in dogs.
Bradley T; Gewertz BL; Scott WJ; Goldberg LI
J Lab Clin Med; 1986 Jun; 107(6):525-8. PubMed ID: 2940307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
